Effect of antidepressant drugs in mice lacking the norepinephrine transporter
- PMID: 16554743
- DOI: 10.1038/sj.npp.1301064
Effect of antidepressant drugs in mice lacking the norepinephrine transporter
Abstract
One of the main theories concerning the mechanism of action of antidepressant drugs (ADs) is based on the notion that the neurochemical background of depression involves an impairment of central noradrenergic transmission with a concomitant decrease of the norepinephrine (NE) in the synaptic gap. Many ADs increase synaptic NE availability by inhibition of the reuptake of NE. Using mice lacking NE transporter (NET-/-) we examined their baseline phenotype as well as the response in the forced swim test (FST) and in the tail suspension test (TST) upon treatment with ADs that display different pharmacological profiles. In both tests, the NET-/- mice behaved like wild-type (WT) mice acutely treated with ADs. Autoradiographic studies showed decreased binding of the beta-adrenergic ligand [3H]CGP12177 in the cerebral cortex of NET-/- mice, indicating the changes at the level of beta-adrenergic receptors similar to those obtained with ADs treatment. The binding of [3H]prazosin to alpha1-adrenergic receptors in the cerebral cortex of NET-/- mice was also decreased, most probably as an adaptive response to the sustained elevation of extracellular NE levels observed in these mice. A pronounced NET knockout-induced shortening of the immobility time in the TST (by ca 50%) compared to WT mice was not reduced any further by NET-inhibiting ADs such as reboxetine, desipramine, and imipramine. Citalopram, which is devoid of affinity for the NET, exerted a significant reduction of immobility time in the NET-/- mice. In the FST, reboxetine, desipramine, imipramine, and citalopram administered acutely did not reduce any further the immobility time shortened by NET knockout itself (ca 25%); however, antidepressant-like action of repeatedly (7 days) administered desipramine was observed in NET-/- mice, indicating that the chronic presence of this drug may also affect other neurochemical targets involved in the behavioral reactions monitored by this test. From the present study, it may be concluded that mice lacking the NET may represent a good model of some aspects of depression-resistant behavior, paralleled with alterations in the expression of adrenergic receptors, which result as an adaptation to elevated levels of extracellular NE.
Similar articles
-
Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior.Neuropsychopharmacology. 2009 Mar;34(4):1067-77. doi: 10.1038/npp.2008.184. Epub 2008 Oct 15. Neuropsychopharmacology. 2009. PMID: 18923403 Free PMC article.
-
The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.Behav Brain Res. 2010 May 1;209(1):99-108. doi: 10.1016/j.bbr.2010.01.022. Epub 2010 Jan 25. Behav Brain Res. 2010. PMID: 20097233 Free PMC article.
-
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.Behav Pharmacol. 2008 Sep;19(5-6):566-74. doi: 10.1097/FBP.0b013e32830cd80f. Behav Pharmacol. 2008. PMID: 18690111 Free PMC article.
-
[Antidepressant drugs and central monoaminergic receptors].Yakubutsu Seishin Kodo. 1985 Dec;5(4):303-19. Yakubutsu Seishin Kodo. 1985. PMID: 2870595 Review. Japanese.
-
Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions.Neuropharmacology. 1983 Mar;22(3 Spec No):415-24. doi: 10.1016/0028-3908(83)90191-0. Neuropharmacology. 1983. PMID: 6304559 Review.
Cited by
-
Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine.Neuropsychopharmacology. 2024 May 2. doi: 10.1038/s41386-024-01868-5. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38698264
-
Modulating Stress Susceptibility and Resilience: Insights from miRNA Manipulation and Neural Mechanisms in Mice.Mol Neurobiol. 2024 Jan 27. doi: 10.1007/s12035-024-03922-1. Online ahead of print. Mol Neurobiol. 2024. PMID: 38280111
-
Chronic Desipramine Reverses Deficits in Cell Activity, Norepinephrine Innervation, and Anxiety-Depression Phenotypes in Fluoxetine-Resistant cF1ko Mice.J Neurosci. 2024 Jan 17;44(3):e1147232023. doi: 10.1523/JNEUROSCI.1147-23.2023. J Neurosci. 2024. PMID: 38050173 Free PMC article.
-
The selective norepinephrine reuptake inhibitor reboxetine promotes late-stage fracture healing in mice.iScience. 2023 Aug 29;26(10):107761. doi: 10.1016/j.isci.2023.107761. eCollection 2023 Oct 20. iScience. 2023. PMID: 37720081 Free PMC article.
-
Postpartum depression in rats causes poor maternal care and neurochemical alterations on dams and long-lasting impairment in sociability on the offspring.Behav Brain Res. 2023 Jan 5;436:114082. doi: 10.1016/j.bbr.2022.114082. Epub 2022 Aug 27. Behav Brain Res. 2023. PMID: 36041571 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
